European Lithium Ltd - Announcement by CVS
RNS Number : 3669M
European Lithium Limited
07 January 2019
 

EUROPEAN LITHIUM LIMITED

ANNOUNCEMENT BY CVS

European Lithium Limited (ASX:EUR)(FRA: PF8)(VSE: ELI)(NEX: EUR) (the "Company") refers its shareholders to the announcement made by Cervantes Corporate Limited ("CVS") (ASX: CVS) today entitled "Drill testing of gold zones at Albury Heath intersect impressive quartz lodes". Link as follows:

https://www.cervantescorp.com.au/pdfs/2019-01-07-044553190107_-_Drill_testing_of_gold_zones_at_Albury_Heath_intersect_impressive_quartz_lodes.pdf

The Company holds 32,000,000 shares in CVS representing 6.47% of the total share capital.

Tony Sage

Non-Executive Chairman

European Lithium Limited

- END -

Visit the Company's website to find out more about the advanced Wolfsberg Lithium Project located in Austria.

For further information please contact:

European Lithium Ltd

+61 861 819 792

Tony Sage

info@europeanlithium.com

 

NEX Corporate Adviser

+44 207 220 1666

James Joyce


James Sinclair-Ford




Tavistock (UK PR & IR Adviser)


Emily Fenton / Oliver Lamb

+44 207 920 3150

+44 778 855 4035

 


This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NEXEAEFXEEANEFF ]]>